Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Girlich

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 6, 2014
Clinical assessment of potential drug interactions of faldaprevir, a hepatitis C virus protease inhibitor, with darunavir/ritonavir, efavirenz, and tenofovirJohn P Sabo, Jens Kort, Charles Ballow, et al.
Msystems|January 11, 2022
Specificities and Commonalities of Carbapenemase-Producing Escherichia coli Isolated in France from 2012 to 2015Rafael Patiño-Navarrete, Isabelle Rosinski-Chupin, Nicolas Cabanel, et al.
ASM Case Reports|May 7, 2026
<i>Enterobacter roggenkampii</i> ST422 with highly conjugative IncP plasmid carrying <i>bla</i> <sub>KPC-2</sub> gene from Lebanon: a case reportSouad Fayad, Dina Daaboul, Delphine Girlich, et al.
Emerging Infectious Diseases|May 23, 2024
IMI-Type Carbapenemase-Producing Enterobacter cloacae Complex, France and Overseas Regions, 2012-2022Cécile Emeraud, Delphine Girlich, Manon Deschamps, et al.
Emerging Infectious Diseases|August 23, 2023
Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, FranceAgnès B Jousset, Laura Bouabdallah, Aurélien Birer, et al.
Antimicrobial Agents and Chemotherapy|January 17, 2023
Structural and Biochemical Features of OXA-517: a Carbapenem and Expanded-Spectrum Cephalosporin Hydrolyzing OXA-48 VariantLaura Dabos, Joanna E Raczynska, Pierre Bogaerts, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 2021
Optimization of the rapid carbapenem inactivation method for use with AmpC hyperproducersMădălina Maria Muntean, Andrei-Alexandru Muntean, François Guerin, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 19, 2023
Emergence and rapid dissemination of highly resistant NDM-14-producing <i>Klebsiella pneumoniae</i> ST147, France, 2022Cécile Emeraud, Aba Mahamat, Agnès B Jousset, et al.
Antibiotics (Basel, Switzerland)|October 27, 2022
Prevalence and Molecular Mechanisms of Carbapenem Resistance among Gram-Negative Bacilli in Three Hospitals of Northern LebanonMariam Rima, Saoussen Oueslati, Laura Dabos, et al.
The Lancet. Microbe|May 11, 2022
Uncovering the novel Enterobacter cloacae complex species responsible for septic shock deaths in newborns: a cohort studyDelphine Girlich, Souad Ouzani, Cécile Emeraud, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 6, 2014
Clinical assessment of potential drug interactions of faldaprevir, a hepatitis C virus protease inhibitor, with darunavir/ritonavir, efavirenz, and tenofovirJohn P Sabo, Jens Kort, Charles Ballow, et al.
Msystems|January 11, 2022
Specificities and Commonalities of Carbapenemase-Producing Escherichia coli Isolated in France from 2012 to 2015Rafael Patiño-Navarrete, Isabelle Rosinski-Chupin, Nicolas Cabanel, et al.
ASM Case Reports|May 7, 2026
<i>Enterobacter roggenkampii</i> ST422 with highly conjugative IncP plasmid carrying <i>bla</i> <sub>KPC-2</sub> gene from Lebanon: a case reportSouad Fayad, Dina Daaboul, Delphine Girlich, et al.
Emerging Infectious Diseases|May 23, 2024
IMI-Type Carbapenemase-Producing Enterobacter cloacae Complex, France and Overseas Regions, 2012-2022Cécile Emeraud, Delphine Girlich, Manon Deschamps, et al.
Emerging Infectious Diseases|August 23, 2023
Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, FranceAgnès B Jousset, Laura Bouabdallah, Aurélien Birer, et al.
Antimicrobial Agents and Chemotherapy|January 17, 2023
Structural and Biochemical Features of OXA-517: a Carbapenem and Expanded-Spectrum Cephalosporin Hydrolyzing OXA-48 VariantLaura Dabos, Joanna E Raczynska, Pierre Bogaerts, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 2021
Optimization of the rapid carbapenem inactivation method for use with AmpC hyperproducersMădălina Maria Muntean, Andrei-Alexandru Muntean, François Guerin, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 19, 2023
Emergence and rapid dissemination of highly resistant NDM-14-producing <i>Klebsiella pneumoniae</i> ST147, France, 2022Cécile Emeraud, Aba Mahamat, Agnès B Jousset, et al.
Antibiotics (Basel, Switzerland)|October 27, 2022
Prevalence and Molecular Mechanisms of Carbapenem Resistance among Gram-Negative Bacilli in Three Hospitals of Northern LebanonMariam Rima, Saoussen Oueslati, Laura Dabos, et al.
The Lancet. Microbe|May 11, 2022
Uncovering the novel Enterobacter cloacae complex species responsible for septic shock deaths in newborns: a cohort studyDelphine Girlich, Souad Ouzani, Cécile Emeraud, et al.
Pageof 14